Investigators studied health-related quality of life (HRQoL) and pain outcomes for patients with metastatic prostate cancer (mCRPC) taking olaparib plus abiraterone.
Investigators studied health-related quality of life (HRQoL) and pain outcomes for patients with metastatic prostate cancer (mCRPC) taking olaparib plus abiraterone.
FLORENCE – North Alabama Medical Center recently welcomed Michael Funderburk, MD, to the medical staff as our newest urologist. Dr. Funderburk comes to NAMC from Advanced Urology in Decatur, Georgia.
Researchers from City of Hope find only 30% of people with neuroendocrine tumors consider living longer to be their single top priority; 70% said addressing and overcoming pain, fatigue, or lack-of-function was more important than just prolonging life. JNCCN announces five new Associate Editors from Duke Cancer Institute, City of Hope, Mayo Clinic Cancer Center, University of Michigan.